COVID-19: Discovery, diagnostics and drug development
T Asselah, D Durantel, E Pasmant, G Lau… - Journal of …, 2021 - Elsevier
Summary Coronavirus disease 2019 (COVID-19) started as an epidemic in Wuhan in 2019,
and has since become a pandemic. Groups from China identified and sequenced the virus …
and has since become a pandemic. Groups from China identified and sequenced the virus …
[PDF][PDF] Liver disease and coronavirus disease 2019: from pathogenesis to clinical care
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel
coronavirus that emerged in late 2019, is posing an unprecedented challenge to global …
coronavirus that emerged in late 2019, is posing an unprecedented challenge to global …
After the hurricane: Anti-COVID-19 drugs development, molecular mechanisms of action and future perspectives
HO Khalifa, YM Al Ramahi - International Journal of Molecular Sciences, 2024 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a new coronavirus in
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
[HTML][HTML] COVID-19 challenges and its therapeutics
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …
death worldwide, making it one of the severe public health issues in recent decades. nCoV …
[HTML][HTML] Drug discovery strategies for SARS-CoV-2
Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …
Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
[HTML][HTML] Outbreak of COVID-19: An emerging global pandemic threat
M Peng - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Since the first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by …
infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by …
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
A Pandey, AN Nikam, AB Shreya, SP Mutalik… - Life sciences, 2020 - Elsevier
The present pandemic of SARS-CoV-2 has been a tough task for the whole world to deal
with. With the absence of specific drugs or vaccines against SARS-CoV-2, the situation is …
with. With the absence of specific drugs or vaccines against SARS-CoV-2, the situation is …
[引用][C] Coronavirus disease COVID-19: a new threat to public health
Coronavirus is zoonotic in nature and belongs to a large family of viruses, however the
actual zoonotic origin is yet to be confirmed. In late 2002, a coronavirus named as Severe …
actual zoonotic origin is yet to be confirmed. In late 2002, a coronavirus named as Severe …
[HTML][HTML] Covid‐19: time for a paradigm change
FM Buonaguro, PA Ascierto, GD Morse… - Reviews in medical …, 2020 - ncbi.nlm.nih.gov
As of May 11, 2020, coronavirus disease 2019 (Covid-19) has been confirmed in 4 152 670
people worldwide, carrying a mortality of approximately 6.8%, 1 compared with a mortality …
people worldwide, carrying a mortality of approximately 6.8%, 1 compared with a mortality …